Expiring federal contract
75N90026P00079 — Werfen USA LLC
Department of Health and Human Services · National Institutes of Health
- Contract / PIID
- 75N90026P00079
- Incumbent
- Werfen USA LLC
- Incumbent UEI
- JA87HT8KP2M2
- Current end date
- January 31, 2027
- Potential total value
- $170,000
- Obligated
- $170,000
- NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6550 — IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Set-aside
- Full & Open
- Start date
- February 1, 2026
- Place of performance
- MA
- Award type
- PURCHASE ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
PURCHASE OF VARIOUS KITS/SUPPLIES FOR ACL TOP ANALYZERS
Likely rebid window (estimate)
- Sources Sought / RFI: about Jan 2026 – Jul 2026 (6–12 months before the end date)
- RFP: about Sep 2026 – Nov 2026 (2–4 months before the end date)
Now inside the estimated RFP window.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325413)
- 75H71025P00975 — Becton, Dickinson And Company · ends November 30, 2026 · $103K
- 75H71226F28022 — Cepheid · ends January 11, 2027 · $460K
- 75H71226F28026 — Cepheid · ends February 7, 2027 · $272K
- 75H71226F28010 — Biomerieux INC · ends February 26, 2027 · $240K
- 75H70722P00094 — Cepheid · ends February 28, 2027 · $2.8M
- 75H70723F80016 — Abbott Laboratories INC. · ends February 28, 2027 · $310K
- 75H71025F80116 — Roche Diabetes Care INC · ends March 31, 2027 · $244K
- 75H71226F28027 — Cepheid · ends April 14, 2027 · $600K
- 75H70726F80013 — Fisher Scientific Company L.L.C. · ends April 30, 2027 · $610K
- 75A50123C00036 — Siro Diagnostics, INC. · ends May 1, 2027 · $28M